improve the assay sensitivity to detect difference between samples by reducing significantly the potential of interferences and therefore reduce instrumental errors.
Introduction
Neuropeptides play a central role in pain transmission and their quantification provides valuable insight on the molecular events associated with the pathophysiology. Moreover, neuropeptides can be used as biomarkers to support the development of new analgesic drugs and assist the decision making process in non-clinical drug development [1] [2] [3] . Mass spectrometry (MS) has a significant role in bioanalytical chemistry workflow. Adequate method selectivity, precision and accuracy are essential and both HPLC-MS/MRM and HPLC-MS/MRM 3 represent interesting options when performing analysis on a hybrid triple quadrupole-linear ion trap mass spectrometer (QqLIT). The vast majority of targeted peptide assays use HPLC-MS/MRM however interferences often occurs while performing analysis of complex biological matrices. HPLC-MS/MRM 3 is a technique which enables a better selectivity compared with a more conventional HPLC-MS/MRM assay and it can be performed on a hybrid QqLIT MS. This analytical approach allows the detection and quantitation by enriching standard MRM with secondary product ions that are generated within the linear ion trap. This strategy is particularly suitable when high background and/or interferences are observed in complex biological matrices (e.g. organs, plasma) and consequently standard MRM methods do not provide adequate selectivity thus affecting the assays figure of merits. Recently, a HPLC-MS/MRM 3 analytical method was
proposed for routine analysis of low-abundance putative protein biomarkers using surrogate tryptic peptides [4] . The authors demonstrated that a technique using in silico reconstructed MRM 3 chromatograms using specific secondary ions produced from a trapped primary product ion, provided enhancements of the selectivity and figures of merits of the assay allowing the analysis of targeted protein biomarkers at trace concentrations in human serum. Thus, our objective was to verify if this analytical strategy could provide significant advantages over a more traditional HPLC-MS/MRM assay for the quantification of specific tachykinin peptides in rat spinal cord.
Substance P (SP) and neurokinin A (NKA) are tachykinin peptides playing a central role in pain transmission [5] . SP and NKA are both pronociceptive peptides and agonists of the receptor neurokinin-1 (NK1) present in the lamina I of the spinal cord [6] [7] . However, NKA binds preferentially to the receptor neurokinin-2 (NK2) expressed at the lower level of the spinal cord.
The interaction frequency between SP, NKA and their postsynaptic receptors strongly correlates with the intensity and duration of pain [5] . Moreover, there is a close link between the upregulation of SP and NKA with an increased release of excitatory amino acids in the intersynaptic space [8] . SP and NKA are essential elements in pain transmission and secondary hyperalgesia.
SP and NKA are both important biomarkers used for preclinical pain pharmacology assessments.
Consequently, the development of a selective, sensitive, precise and accurate analytical method is essential to test our hypotheses linking SP and NKA with pain behaviors.
Materials and Methods

Chemicals
Substance P and neurokinin A were purchased from Phoenix Pharmaceutical (Belmont, CA, USA). Deuterium labeled analog peptides were synthesized and used as internal standards (CanPeptide, Inc., Pointe-Claire, QC, Canada). Acetonitrile was purchased from Fisher Scientific (NJ, USA). Trifluoroacetic acid (TFA) and formic acid (FA) were purchased from J.T. Baker (Phillipsburg, NJ, USA). Standard solutions were prepared using a 0.25% TFA aqueous solution.
Sample preparation
Deuterated peptides were specifically labeled on glycine and leucine residues (SP: The samples were sonicated for 20 min and 150 µL of the homogenate were mixed with 150 µL of acetonitrile to precipitate high molecular weight proteins. The samples were vortexed and centrifuged at 12,000 g for 10 min. Then 150 µL of the supernatant were mixed with 150 µL of the internal standard solution (deuterium labeled peptides). The samples were then transferred into an injection vial for analysis.
Bioanalytical method
The HPLC-MS/MRM and HPLC-MS/MRM 3 analyses were performed using a Perkin Elmer was maintained from 13 to 15 min. At 15.1 min, the mobile phase composition was reverted to 5:95 (A:B) and the column was allowed to equilibrate for 10 min for a total run time of 25 min.
The flow rate was fixed at 300 µL/min and SP and NKA eluted at 13.1 and 12.4 min respectively.
The eluates were analyzed using an AB SCIEX API 2000 QTRAP mass spectrometer interface with pneumatic assisted electrospray ion source. The nitrogen gas 1 was set to 25 PSI, the nitrogen gas 2 was set to 40 PSI and the electrospray electrode was set to 5000V. The declustering potential (DP) was set to 30V. The mass spectrometer was operated in MRM or MRM 3 mode using specific mass transitions with a collision energy set to 22V. The MRM transitions were acquired with a dwell time fixed to 200 ms for each mass transition. In MRM 3 mode, ion trap fill time and excitation time was set to 200 and 25 ms, respectively. In all MRM 3 experiments, the scan rate was set to 4000 amu/s and a Q0 trapping was used. Details on selected ions used for HPLC-MS/MRM and HPLC-MS/MRM 3 analysis are reported in Table 1 .
Regression analyses were performed with PRISM (version 6.0c) GraphPad software (La Jolla, CA, USA) using nonlinear curve-fitting module with an estimation of the goodness of fit. The calibration lines were constructed from the light and heavy peptide isotopes peak-area ratios of targeted neuropeptides.
Results and discussion
Full-scan MS, MS 2 , MS 3 spectra were recorded in positive mode to determine the most sensitive chromatograms were generated using the three most abundant secondary MS 3 fragment ions and was judged to be the best compromise in order to preserve adequate sensitivity and improve selectivity. However, the sensitivity (i.e. signal-to-noise ratio) was severely reduced as illustrated in Fig.2 and could be an important limiting factor for the analysis of low abundant peptides. The measured endogenous levels for the tested rat spinal cords (n=6) were 53.1 (± 9.5) pg/mg and 60.1 (± 7.8) pg/mg for SP and NKA respectively using HPLC-MS/MRM. The results
were not statistically different using HPLC-MS/MRM 3 with endogenous levels of 49.6 (± 7. Each spiked sample was analyzed in six replicates including blanks along with standards prepared at concentrations ranging from 20 to 500 ng/mL to measure endogenous levels. In Table 2 , the precision and accuracy data showed that both methods provided acceptable figures of merit with a marked better precision at the low concentrations in HPLC-MS/MRM 3 . As shown in Fig 2, interferences are present in HPLC-MS/MRM and it will inherently affect peak integration and consequently the precision of the method. Generally, analysis of neuropeptides are performed near the endogenous values and the added improvement in selectivity provided by HPLC-MS/MRM 3 analysis may have a significant positive impact on the precision of the measured signal and consequently improve the sensitivity of the method to detect biologically significant differences between samples.
Conclusion
The strict comparison between the statistics of the analysis of SP and NKA by HPLC-MS/MRM and HPLC-MS/MRM 3 does not provide compelling arguments in favor of HPLC-MS/MRM 3 particularly due to tradeoff in absolute signal sensitivity. However, following the examination of the extracted ion chromatograms provided by both approaches (Fig. 2) , the added selectivity 
